Squamous Cell Anal Carcinoma

1

Review clinical trials related to Squamous Cell Anal Carcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Combination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma

This study evaluates the feasibility of the combination of radiotherapy, chemotherapies (docetaxel, cisplatin and 5-fluorouracil) and spartalizumab (anti-PD-1 therapy) in patients with metastatic squamous cell anal carcinoma

Participants needed: 34
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Centre Hospitalier Universitaire de BesanconUpdated: Dec 22, 2023Locations: 5
Eligibility criteria

Male or female, aged ≥18 years, [+18]

HIV positive patient , CD4 count < 400 cells/mm3 (HIV test mandatory before incl... [+29]